Lee v. Williams

2018 UT App 54, 420 P.3d 88
CourtCourt of Appeals of Utah
DecidedMarch 29, 2018
Docket20160198-CA
StatusPublished
Cited by3 cases

This text of 2018 UT App 54 (Lee v. Williams) is published on Counsel Stack Legal Research, covering Court of Appeals of Utah primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Lee v. Williams, 2018 UT App 54, 420 P.3d 88 (Utah Ct. App. 2018).

Opinion

HARRIS, Judge:

¶1 During her first pregnancy, Kylie Lee sustained a permanent injury while under the care of Dr. Kenneth Williams. This injury occurred because Lee did not receive a particular medication during her pregnancy that almost certainly would have prevented the injury. As a result of the injury, all of Lee's future pregnancies now carry a substantial risk of birth defects or miscarriage. In fact, Lee's subsequent pregnancy came with serious complications. After the birth of her second child, Lee sued Williams for negligence.

¶2 Williams defended the case, in part, on statute of limitations grounds. During pretrial proceedings, the trial court narrowed the issues to be tried by ruling on summary judgment that, while genuine issues of material fact precluded a summary ruling regarding when Lee learned that she was injured, Lee knew no later than March 2009 that Williams may have been negligent. A few months later, after a bifurcated trial, the issue of when Lee discovered her injury was submitted to a jury. The jury found that Lee knew that she "might have sustained an injury" prior to September 2010, more than two years before she filed her complaint. The court then dismissed Lee's lawsuit on the grounds that it was not timely filed.

¶3 Lee now appeals, and asks us to consider two main arguments. First, she contends that the trial court should not have determined, on summary judgment, that she knew of Williams's negligence by March 2009. Second, Lee contends that the trial court made several errors during the trial, including an error regarding a jury instruction and an erroneous decision to exclude certain evidence. We disagree with Lee's first argument, and conclude that the trial court's summary judgment ruling was sound. We agree, in large part, with Lee's second argument, however, and conclude that the trial court committed three errors in the course of the trial, and that at least two of these errors were not harmless. Accordingly, we affirm in part and reverse in part, and remand the case for a new trial.

BACKGROUND

Medical History

¶4 In 2008, Lee became pregnant and began receiving ongoing medical care from Williams, an employee of Moab Family Medicine, PC. During the course of this treatment, Williams determined that Lee's blood was "Type A" and "Rh-negative."

¶5 Human blood is categorized into types, denoted by a letter or letters (for example, Type A, Type AB, Type O). In addition, human blood is further categorized, in a binary way, relative to its "Rh-factor." A person's blood is "Rh-negative" if it does not have a specific particle (called the "D particle") on the surface of its red blood cells. Blood that has the D particle is "Rh-positive." When describing blood type, these terms are often shortened to simply "negative" and "positive," and are often combined with the letter category, so that a person's blood is referred to, for instance, as "A-negative" or "O-positive." Williams testified at trial that mixing blood of different types and Rh-factors can cause medical complications, and that concerns about such complications sometimes arise during pregnancy, because a pregnant woman may have a different blood type and Rh-factor than her fetus.

¶6 The medical complication pertinent to this case arises when a pregnant woman with Rh-negative blood mixes that blood with an Rh-positive fetus. In that circumstance, Williams testified that the woman may become "Rh-sensitized," which causes her body to react to the fetus's Rh-positive blood as if it is an infection or a foreign substance. Once a woman is Rh-sensitized, she is permanently Rh-sensitized. An Rh-sensitized woman has no symptoms until she has a fetus with Rh-positive blood, at which point the woman's body may break down the fetus's blood cells, potentially causing severe harm to the fetus and sometimes even resulting in a miscarriage.

¶7 In this case, as it turned out, Lee's blood type was Rh-negative and her first baby's blood type was Rh-positive, creating a risk for Rh-sensitization if their blood mixed. To protect against Rh-sensitization, doctors can administer an injectable medication called RhoGAM, which Williams testified significantly reduces the risk of Rh-sensitization. RhoGAM is preventative; that is, it can only prevent Rh-sensitization, and cannot undo the sensitization once it has occurred. Accordingly, RhoGAM has no beneficial effect if the woman who receives it is already Rh-sensitized. In cases like Lee's, where a pregnant woman is Rh-negative and her fetus is Rh-positive, a doctor would typically order that she receive RhoGAM twice, once between 26 and 28 weeks gestation, and once upon delivery.

¶8 At the outset of her first pregnancy, Lee was not yet Rh-sensitized, and so RhoGAM

treatments to prevent sensitization would have been appropriate. While Williams maintains both (a) that he informed Lee that she needed a RhoGAM injection at 26-28 weeks and (b) that he ordered such an injection, there is no evidence to support these contentions in the contemporaneously created medical records. In any case, it is undisputed that Lee did not receive a RhoGAM injection at 26-28 weeks, or at any other time prior to delivery of her first child.

¶9 Lee gave birth to her first child on December 30, 2008. Williams would later testify that the infant suffered complications associated with Rh-positive infants born to Rh-sensitized mothers, prompting him to suspect that Lee had become Rh-sensitized. Accordingly, Williams ordered tests to determine whether Lee was Rh-sensitized. Despite Williams's suspicions that Lee may already have been Rh-sensitized, Lee received a RhoGAM injection-her first-after the baby's birth. Lee testified at trial that the nurse who gave her the injection indicated that Lee needed it because she was Rh-negative and would need additional injections during every subsequent pregnancy. As noted previously, RhoGAM has no beneficial effects for women who are already Rh-sensitized.

¶10 Williams maintains that, on December 31, 2008, the day after the first child's birth, he informed Lee that she had become Rh-sensitized and that she would potentially suffer complications and miscarriages in future pregnancies as a result. However, there is no confirmation of this in any medical record, and Williams acknowledges that, prior to January 5, 2009, he had not yet received lab results confirming that Lee was Rh-sensitized; he characterized his misgivings that Lee may have been sensitized as merely a "suspicion" prior to that date. Also, there is no evidence in any of Williams's records that Lee was informed of her sensitization after the lab results were received on January 5, 2009, and Rh-sensitization is not mentioned in the records for any of the ten doctor's visits she had after the test.

¶11 A few weeks later, in March 2009, Lee conducted some independent Internet searches regarding RhoGAM. Lee maintains that she engaged in these searches because she remembered the nurse giving her a RhoGAM injection following her delivery and became curious about what that meant. During her Internet searches, Lee learned that RhoGAM was meant to prevent Rh-sensitization. Lee claims that, at this time, she also learned for the first time that she should have received a RhoGAM injection during her pregnancy. Lee maintains, however, that because she received a RhoGAM injection after delivering her first child, she believed she was not Rh-sensitized at that point.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Johansen v. Johansen
2021 UT App 130 (Court of Appeals of Utah, 2021)
Dale K. Barker Co PC CPA Profit Sharing v. Turner
2021 UT App 119 (Court of Appeals of Utah, 2021)
Nat'l Title Agency LLC v. JPMorgan Chase Bank NA
2018 UT App 145 (Court of Appeals of Utah, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
2018 UT App 54, 420 P.3d 88, Counsel Stack Legal Research, https://law.counselstack.com/opinion/lee-v-williams-utahctapp-2018.